Full Text
PRS34 Cost-Effectiveness of Roflumilast (DAXAS®) in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) in Spain

Abstract

Authors

L. Lindner L. Camins de Valdenebro J. Aparicio Martinez

Back to Volume 14, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×